Skip to main content

Jessica Hagen

By Jessica Hagen | 11:12 am | March 06, 2023
In an exclusive interview, Varjo and machineMD discuss their partnership to develop Neos, a VR-powered eye-tracking tool that aims to help providers detect brain disorders.
By Jessica Hagen | 11:19 am | March 03, 2023
The funds will be used to open new clinics in the U.S.
By Jessica Hagen | 01:36 pm | March 02, 2023
Drug-discovery platform TandemAI, sleep-care platform BetterNight, health-monitoring system Xandar Kardian and AR/VR platform Healium also announced funding rounds.
By Jessica Hagen | 11:49 am | March 02, 2023
The multinational pharma company will access Tempus' AI-enabled data library to further therapeutic development and advance its portfolio in oncology.
By Jessica Hagen | 11:29 am | March 01, 2023
The mental health platform let go of 15% of its workforce.
By Jessica Hagen | 03:15 pm | February 28, 2023
DenovAI will create an AI-powered platform to discover potential antibodies from scratch, then suggest which ones can be used as effective drugs.
By Jessica Hagen | 01:55 pm | February 28, 2023
Rock Health’s 2022 Digital Health Consumer Adoption Survey also found non-video telehealth offerings have become more popular.
By Jessica Hagen | 01:09 pm | February 27, 2023
A Pew Research Center survey of more than 11,000 U.S. adults reveals the majority would feel uncomfortable if their healthcare provider relied on AI for their care.
By Jessica Hagen | 12:46 pm | February 24, 2023
Users will have access to symptom tracking and educational content, while its enterprise customers can obtain additional on-demand coaching and support.
By Jessica Hagen | 02:35 pm | February 23, 2023
The latest funding builds off a Series B announced in April.